Skip to Content
 
David F.  Penson

David F. Penson, M.D., M.P.H.

Chair, Department of Urologic Surgery
Paul V. Hamilton, MD and Virginia E. Howd Professor of Urologic Oncology
Co-Leader, Cancer Health Outcomes and Control Research Program
Director, Center for Surgical Quality and Outcomes Research
Urologic Surgeon/Oncologist

  • Appointments
    615-322-2880
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Nashville Veterans Affairs Medical Center
    (615) 327-4751 or (800) 228-4973

    Office
    615-343-1529
  • Faxes
    Nashville Veterans Affairs Medical Center Fax
    (615) 873-7901
    Office Fax
    615-875-2655
    Clinic Fax
    615-343-9815
  • Addresses
    Nashville Veterans Affairs Medical Center
    1310 24th Ave. South
    Nashville , TN 37212-2637
    Website

    Office
    Vanderbilt University Medical Center
    2525 West End Avenue, Suite 1200
    Nashville, TN 37203-1738
Profile

Dr. Penson is a board-certified urologic oncologist who focuses on urological malignancies, particularly bladder and prostate cancer. He is an internationally recognized expert in the care of both of these common cancers and is also a federally funded researcher with a focus on patient-reported outcomes, survivorship and comparative effectiveness in prostate cancer. He serves as the American Urologic Association National Chair for Healthcare Policy and is the organization's representative to the Commission on Cancer.

Education
  • M.D. - Boston University, 1991
  • M.P.H. - Yale University, 2000
Postgraduate Training
  • General Surgery Internship - UCLA Health System, 1992
  • General Surgery Residency - UCLA Health System, 1993
  • Urology Residency - UCLA Health System, 1997
  • Fellowship - Yale University School of Medicine, 1999
Publications
  • Kavitt RT, Penson DF, Vaezi MF. Eosinophilic esophagitis: dilate or medicate? A cost analysis model of the choice of initial therapy. Dis. Esophagus [print-electronic]. 2014 Jul; 27(5): 418-23. PMID: 22947137, PMCID: PMC3823713, DOI: 10.1111/j.1442-2050.2012.01409.x, ISSN: 1442-2050.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22947137.
  • Penson DF. Capsule commentary on Shahinian et al.: Patterns of bone mineral density testing in men receiving androgen deprivation for prostate cancer. J Gen Intern Med. 2013 Nov; 28(11): 1494. PMID: 23784368, PMCID: PMC3797357, DOI: 10.1007/s11606-013-2513-2, ISSN: 1525-1497.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23784368.
  • Penson DF. Post-prostatectomy incontinence and pelvic floor muscle training: a defining problem [editorial]. Eur. Urol [print-electronic]. 2013 Nov; 64(5): 773-5; discussion 775. PMID: 23499365, PII: S0302-2838(13)00233-9, DOI: 10.1016/j.eururo.2013.03.009, ISSN: 1873-7560.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23499365.
  • Keegan KA, Penson DF. The Patient Protection and Affordable Care Act: the impact on urologic cancer care. Urol. Oncol [print-electronic]. 2013 Oct; 31(7): 980-4. PMID: 22819697, PMCID: PMC3773249, PII: S1078-1439(12)00011-7, DOI: 10.1016/j.urolonc.2012.01.007, ISSN: 1873-2496.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22819697.
  • Morgan TM, Barocas DA, Chang SS, Phillips SE, Salem S, Clark PE, Penson DF, Smith JA, Cookson MS. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol. Oncol [print-electronic]. 2013 Aug; 31(6): 871-7. PMID: 21906965, PMCID: PMC3253245, PII: S1078-1439(11)00232-8, DOI: 10.1016/j.urolonc.2011.07.012, ISSN: 1873-2496.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21906965.
  • Penson DF. Editorial comment [editorial]. J. Urol [print-electronic]. 2013 Aug; 190(2): 398. PMID: 23624150, PII: S0022-5347(13)04123-2, DOI: 10.1016/j.juro.2013.02.3237, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23624150.
  • Penson DF. Time to raise the bar in localised prostate cancer [editorial]. BJU Int. 2013 Aug; 112(3): 278. PMID: 23826836, DOI: 10.1111/bju.12328, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23826836.
  • Barocas DA, Grubb R, Black A, Penson DF, Fowke JH, Andriole G, Crawford ED. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer [print-electronic]. 2013 Jun 6/15/2013; 119(12): 2223-9. PMID: 23559420, DOI: 10.1002/cncr.28042, ISSN: 1097-0142.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23559420.
  • Reynolds WS, Dmochowski RR, Lai J, Saigal C, Penson DF, . Patterns and predictors of urodynamics use in the United States. J. Urol [print-electronic]. 2013 May; 189(5): 1791-6. PMID: 23159270, PMCID: PMC3984034, PII: S0022-5347(12)05556-5, DOI: 10.1016/j.juro.2012.11.066, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23159270.
  • Reynolds WS, Gold KP, Ni S, Kaufman MR, Dmochowski RR, Penson DF. Immediate effects of the initial FDA notification on the use of surgical mesh for pelvic organ prolapse surgery in medicare beneficiaries. Neurourol. Urodyn [print-electronic]. 2013 Apr; 32(4): 330-5. PMID: 23001605, PMCID: PMC3962985, DOI: 10.1002/nau.22318, ISSN: 1520-6777.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23001605.
  • Anderson CB, Morgan TM, Kappa S, Moore D, Clark PE, Davis R, Penson DF, Barocas DA, Smith JA, Cookson MS, Chang SS. Ureteroenteric anastomotic strictures after radical cystectomy-does operative approach matter?. J. Urol [print-electronic]. 2013 Feb; 189(2): 541-7. PMID: 23260561, PII: S0022-5347(12)04846-X, DOI: 10.1016/j.juro.2012.09.034, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23260561.
  • Anderson CB, Penson DF, Ni S, Makarov DV, Barocas DA. Centralization of radical prostatectomy in the United States. J. Urol [print-electronic]. 2013 Feb; 189(2): 500-6. PMID: 23069384, PII: S0022-5347(12)05193-2, DOI: 10.1016/j.juro.2012.10.012, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23069384.
  • Kaffenberger SD, Keegan KA, Bansal NK, Morgan TM, Tang DH, Barocas DA, Penson DF, Davis R, Clark PE, Chang SS, Cookson MS, Herrell SD, Smith JA. Salvage robotic assisted laparoscopic radical prostatectomy: a single institution, 5-year experience. J. Urol [print-electronic]. 2013 Feb; 189(2): 507-13. PMID: 23000849, PMCID: PMC3698478, PII: S0022-5347(12)04913-0, DOI: 10.1016/j.juro.2012.09.057, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23000849.
  • Resnick MJ, Guzzo TJ, Cowan JE, Knight SJ, Carroll PR, Penson DF. Factors associated with satisfaction with prostate cancer care: results from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). BJU Int [print-electronic]. 2013 Feb; 111(2): 213-20. PMID: 22928860, PMCID: PMC3540193, DOI: 10.1111/j.1464-410X.2012.11423.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22928860.
  • Resnick MJ, Koyama T, Fan KH, Albertsen PC, Goodman M, Hamilton AS, Hoffman RM, Potosky AL, Stanford JL, Stroup AM, Van Horn RL, Penson DF. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 2013 Jan 1/31/2013; 368(5): 436-45. PMID: 23363497, PMCID: PMC3742365, DOI: 10.1056/NEJMoa1209978, ISSN: 1533-4406.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23363497.
  • Morgan TM, Barocas DA, Keegan KA, Cookson MS, Chang SS, Ni S, Clark PE, Smith JA, Penson DF. Volume outcomes of cystectomy--is it the surgeon or the setting?. J. Urol [print-electronic]. 2012 Dec; 188(6): 2139-44. PMID: 23083864, PII: S0022-5347(12)04499-0, DOI: 10.1016/j.juro.2012.08.042, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23083864.
  • Penson DF. Factors influencing patients' acceptance and adherence to active surveillance. J. Natl. Cancer Inst. Monographs. 2012 Dec; 2012(45): 207-12. PMID: 23271775, PMCID: PMC3540870, PII: lgs024, DOI: 10.1093/jncimonographs/lgs024, ISSN: 1745-6614.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23271775.
  • Resnick MJ, Penson DF. Quality of life with advanced metastatic prostate cancer. Urol. Clin. North Am [print-electronic]. 2012 Nov; 39(4): 505-15. PMID: 23084527, PII: S0094-0143(12)00055-9, DOI: 10.1016/j.ucl.2012.07.007, ISSN: 1558-318X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23084527.
  • Barocas DA, Gray DT, Fowke JH, Mercaldo ND, Blume JD, Chang SS, Cookson MS, Smith JA, Penson DF. Racial variation in the quality of surgical care for prostate cancer. J. Urol [print-electronic]. 2012 Oct; 188(4): 1279-85. PMID: 22902011, PMCID: PMC3770766, PII: S0022-5347(12)03947-X, DOI: 10.1016/j.juro.2012.06.037, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22902011.
  • Morgan TM, Barocas DA, Penson DF, Chang SS, Ni S, Clark PE, Smith JA, Cookson MS. Lymph node yield at radical cystectomy predicts mortality in node-negative and not node-positive patients. Urology [print-electronic]. 2012 Sep; 80(3): 632-40. PMID: 22795379, PII: S0090-4295(12)00607-3, DOI: 10.1016/j.urology.2012.03.070, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22795379.
  • Penson DF, Lange PH. Systemic therapy and the urologic oncologist: a unique opportunity for the specialty to provide comprehensive care that ultimately benefits the patient. Urol. Oncol. 2012 Jul; 30(4 Suppl): S2-4. PMID: 22795076, PII: S1078-1439(11)00137-2, DOI: 10.1016/j.urolonc.2011.04.008, ISSN: 1873-2496.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22795076.
  • Penson DF. Editorial comment [editorial]. J. Urol [print-electronic]. 2012 Apr; 187(4): 1398. PMID: 22341284, PII: S0022-5347(12)00018-3, DOI: 10.1016/j.juro.2011.11.119, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22341284.
  • Patel SG, Penson DF, Pabla B, Clark PE, Cookson MS, Chang SS, Herrell SD, Smith JA, Barocas DA. National trends in the use of partial nephrectomy: a rising tide that has not lifted all boats. J. Urol [print-electronic]. 2012 Mar; 187(3): 816-21. PMID: 22248514, PII: S0022-5347(11)05558-3, DOI: 10.1016/j.juro.2011.10.173, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22248514.
  • Penson DF. Re: how well informed are women who undergo urodynamic testing?. J. Urol [print-electronic]. 2012 Mar; 187(3): 965. PMID: 22325520, PII: S0022-5347(11)05706-5, DOI: 10.1016/j.juro.2011.11.049, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22325520.
  • Penson DF. Re: physician documentation of fluoroscopy time in voiding cystourethrography reports correlates with lower fluoroscopy times: a surrogate marker of patient radiation exposure. J. Urol [print-electronic]. 2012 Mar; 187(3): 965-6. PMID: 22325521, PII: S0022-5347(11)05707-7, DOI: 10.1016/j.juro.2011.11.050, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22325521.
  • Penson DF. Re: urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in medicare population. J. Urol [print-electronic]. 2012 Mar; 187(3): 966-7. PMID: 22325522, PII: S0022-5347(11)05708-9, DOI: 10.1016/j.juro.2011.11.051, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22325522.
  • Penson DF. Re: US physician practices versus Canadians: spending nearly four times as much money interacting with payers. J. Urol [print-electronic]. 2012 Feb; 187(2): 648. PMID: 22237371, PII: S0022-5347(11)05438-3, DOI: 10.1016/j.juro.2011.10.115, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22237371.
  • Penson DF. Re: higher fees paid to us physicians drive higher spending for physician services compared to other countries. J. Urol [print-electronic]. 2012 Feb; 187(2): 647-8. PMID: 22237370, PII: S0022-5347(11)05437-1, DOI: 10.1016/j.juro.2011.10.114, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22237370.
  • Penson DF. Re: today's 'meaningful use' standard for medication orders by hospitals may save few lives; later stages may do more. J. Urol [print-electronic]. 2012 Feb; 187(2): 646. PMID: 22237369, PII: S0022-5347(11)05436-X, DOI: 10.1016/j.juro.2011.10.113, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22237369.
  • Makarov DV, Desai RA, Yu JB, Sharma R, Abraham N, Albertsen PC, Penson DF, Gross CP. The population level prevalence and correlates of appropriate and inappropriate imaging to stage incident prostate cancer in the medicare population. J. Urol [print-electronic]. 2012 Jan; 187(1): 97-102. PMID: 22088337, PII: S0022-5347(11)04987-1, DOI: 10.1016/j.juro.2011.09.042, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22088337.
  • Penson DF. Re: Fifteen-year trend in the use of male reproductive surgery: analysis of the healthcare cost and utilization project data. J. Urol [print-electronic]. 2012 Jan; 187(1): 246. PMID: 22153470, PII: S0022-5347(11)05174-3, DOI: 10.1016/j.juro.2011.09.118, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22153470.
  • Penson DF. Re: Satisfaction profiles in men using intracavernosal injection therapy. J. Urol [print-electronic]. 2012 Jan; 187(1): 245-6. PMID: 22153468, PII: S0022-5347(11)05173-1, DOI: 10.1016/j.juro.2011.09.117, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22153468.
  • Wein AJ, Penson DF. Re: Retropubic versus transobturator midurethral slings for stress incontinence. J. Urol [print-electronic]. 2012 Jan; 187(1): 202-4. PMID: 22153438, PII: S0022-5347(11)05195-0, DOI: 10.1016/j.juro.2011.09.139, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22153438.
  • Wein AJ, Penson DF. Re: Transobturator TVT-O versus retropubic TVT: results of a multicenter randomized controlled trial at 24 months follow-up. J. Urol. 2012 Jan; 187(1): 203-4. PMID: 22268241, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22268241.
  • Wein AJ, Penson DF. Re: What patients think: patient-reported outcomes of retropubic versus trans-obturator mid-urethral slings for urodynamic stress incontinence--a multi-centre randomised controlled trial. J. Urol. 2012 Jan; 187(1): 203-5. PMID: 22268242, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22268242.
  • Fowke JH, Motley SS, Concepcion RS, Penson DF, Barocas DA. Obesity, body composition, and prostate cancer. BMC Cancer. 2012; 12: 23. PMID: 22257467, PMCID: PMC3292483, PII: 1471-2407-12-23, DOI: 10.1186/1471-2407-12-23, ISSN: 1471-2407.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22257467.
  • Davies JD, Aghazadeh MA, Phillips S, Salem S, Chang SS, Clark PE, Cookson MS, Davis R, Herrell SD, Penson DF, Smith JA, Barocas DA. Prostate size as a predictor of Gleason score upgrading in patients with low risk prostate cancer. J. Urol [print-electronic]. 2011 Dec; 186(6): 2221-7. PMID: 22014803, PII: S0022-5347(11)04534-4, DOI: 10.1016/j.juro.2011.07.104, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22014803.
  • Penson DF, Munro HM, Signorello LB, Blot WJ, Fowke JH, . Obesity, physical activity and lower urinary tract symptoms: results from the Southern Community Cohort Study. J. Urol [print-electronic]. 2011 Dec; 186(6): 2316-22. PMID: 22014824, PMCID: PMC3327364, PII: S0022-5347(11)04497-1, DOI: 10.1016/j.juro.2011.07.067, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22014824.
  • Penson DF. Re: Assessment of quality of cancer-related follow-up care from the cancer survivor's perspective. J. Urol [print-electronic]. 2011 Dec; 186(6): 2349. PMID: 22078617, PII: S0022-5347(11)05233-5, DOI: 10.1016/j.juro.2011.08.127, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22078617.
  • Penson DF. Re: Validating the patient safety indicators in the Veterans Health Administration: are they ready for prime time?. J. Urol [print-electronic]. 2011 Dec; 186(6): 2347-8. PMID: 22078616, PII: S0022-5347(11)04760-4, DOI: 10.1016/j.juro.2011.08.038, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22078616.
  • Fowke JH, Munro H, Signorello LB, Blot WJ, Penson DF, . Association between socioeconomic status (SES) and lower urinary tract symptom (LUTS) severity among black and white men. J Gen Intern Med [print-electronic]. 2011 Nov; 26(11): 1305-10. PMID: 21720905, PMCID: PMC3208454, DOI: 10.1007/s11606-011-1776-8, ISSN: 1525-1497.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21720905.
  • Reynolds WS, Dmochowski RR, Penson DF. Epidemiology of stress urinary incontinence in women. Curr Urol Rep. 2011 Oct; 12(5): 370-6. PMID: 21720817, DOI: 10.1007/s11934-011-0206-0, ISSN: 1534-6285.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21720817.
  • Birkhahn M, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG, Cote RJ. Long-term outcome in patients with a Gleason score = 6 prostate cancer treated by radical prostatectomy. BJU Int [print-electronic]. 2011 Sep; 108(5): 660-4. PMID: 21223479, DOI: 10.1111/j.1464-410X.2010.09978.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21223479.
  • Morgan TM, Keegan KA, Barocas DA, Ruhotina N, Phillips SE, Chang SS, Penson DF, Clark PE, Smith JA, Cookson MS. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J. Urol [print-electronic]. 2011 Sep; 186(3): 829-34. PMID: 21788035, PII: S0022-5347(11)03870-5, DOI: 10.1016/j.juro.2011.04.089, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21788035.
  • Zeliadt SB, Penson DF, Moinpour CM, Blough DK, Fedorenko CR, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Provider and partner interactions in the treatment decision-making process for newly diagnosed localized prostate cancer. BJU Int [print-electronic]. 2011 Sep; 108(6): 851-6; discussion 856. PMID: 21244609, DOI: 10.1111/j.1464-410X.2010.09945.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21244609.
  • Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts LJ, Morrow J, Concepcion RS, Smith JA, Fowke JH. Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J. Urol [print-electronic]. 2011 Jun; 185(6): 2102-7. PMID: 21496850, PMCID: PMC3093434, PII: S0022-5347(11)00255-2, DOI: 10.1016/j.juro.2011.02.020, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21496850.
  • McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, Foster HE, Gonzalez CM, Kaplan SA, Penson DF, Ulchaker JC, Wei JT. Update on AUA guideline on the management of benign prostatic hyperplasia. J. Urol [print-electronic]. 2011 May; 185(5): 1793-803. PMID: 21420124, PII: S0022-5347(11)00224-2, DOI: 10.1016/j.juro.2011.01.074, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21420124.
  • Wessells H, Penson DF, Cleary P, Rutledge BN, Lachin JM, McVary KT, Schade DS, Sarma AV, . Effect of intensive glycemic therapy on erectile function in men with type 1 diabetes. J. Urol [print-electronic]. 2011 May; 185(5): 1828-34. PMID: 21420129, PMCID: PMC3220602, PII: S0022-5347(10)05440-6, DOI: 10.1016/j.juro.2010.12.098, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21420129.
  • Makarov DV, Yu JB, Desai RA, Penson DF, Gross CP. The association between diffusion of the surgical robot and radical prostatectomy rates. Med Care. 2011 Apr; 49(4): 333-9. PMID: 21368677, DOI: 10.1097/MLR.0b013e318202adb9, ISSN: 1537-1948.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21368677.
  • Penson DF. Re: Complementary and Alternative Medicine (CAM) Use in Women With Pelvic Floor Disorders: A Cohort Study. J. Urol. 2011 Apr; 185(4): 1382-3. PMID: 22098975, PII: S0022-5347(11)60300-5, DOI: 10.1016/S0022-5347(11)60300-5, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22098975.
  • Penson DF. Re: Treatment Outcomes and Resource Use of Patients With Neurogenic Detrusor Overactivity Receiving Botulinum Toxin A (BOTOX) Therapy in Germany. J. Urol. 2011 Apr; 185(4): 1383-4. PMID: 22098977, PII: S0022-5347(11)60302-9, DOI: 10.1016/S0022-5347(11)60302-9, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22098977.
  • Penson DF. Re: can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. J. Urol. 2011 Apr; 185(4): 1383. PMID: 22098976, PII: S0022-5347(11)60301-7, DOI: 10.1016/S0022-5347(11)60301-7, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22098976.
  • Thong MS, van de Poll-Franse L, Hoffman RM, Albertsen PC, Hamilton AS, Stanford JL, Penson DF. Diabetes mellitus and health-related quality of life in prostate cancer: 5-year results from the Prostate Cancer Outcomes Study. BJU Int [print-electronic]. 2011 Apr; 107(8): 1223-31. PMID: 21070583, PMCID: PMC3292346, DOI: 10.1111/j.1464-410X.2010.09861.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21070583.
  • Epplein M, Zheng Y, Zheng W, Chen Z, Gu K, Penson D, Lu W, Shu XO. Quality of life after breast cancer diagnosis and survival. J. Clin. Oncol [print-electronic]. 2011 Feb 2/1/2011; 29(4): 406-12. PMID: 21172892, PMCID: PMC3058286, PII: JCO.2010.30.6951, DOI: 10.1200/JCO.2010.30.6951, ISSN: 1527-7755.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21172892.
  • Hamilton AS, Albertsen PC, Johnson TK, Hoffman R, Morrell D, Deapen D, Penson DF. Trends in the treatment of localized prostate cancer using supplemented cancer registry data. BJU Int [print-electronic]. 2011 Feb; 107(4): 576-84. PMID: 20735387, PII: BJU9514, DOI: 10.1111/j.1464-410X.2010.09514.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20735387.
  • Padmanabhan P, Scarpero HM, Milam DF, Dmochowski RR, Penson DF. Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overactivity. World J Urol [print-electronic]. 2011 Feb; 29(1): 51-7. PMID: 21110030, DOI: 10.1007/s00345-010-0618-3, ISSN: 1433-8726.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21110030.
  • Ramsey SD, Zeliadt SB, Fedorenko CR, Blough DK, Moinpour CM, Hall IJ, Smith JL, Ekwueme DU, Fairweather ME, Thompson IM, Keane TE, Penson DF. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol [print-electronic]. 2011 Feb; 29(1): 3-9. PMID: 20959991, DOI: 10.1007/s00345-010-0602-y, ISSN: 1433-8726.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20959991.
  • Penson DF. Treatment for postprostatectomy incontinence: is this as good as it gets? [editorial]. JAMA. 2011 Jan 1/12/2011; 305(2): 197-8. PMID: 21224463, PII: 305/2/197, DOI: 10.1001/jama.2010.1984, ISSN: 1538-3598.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21224463.
  • Maripuri S, Penson DF, Ikizler TA, Cavanaugh KL. Outpatient versus inpatient observation after percutaneous native kidney biopsy: a cost minimization study. Am. J. Nephrol [print-electronic]. 2011; 34(1): 64-70. PMID: 21677428, PMCID: PMC3123742, PII: 000328901, DOI: 10.1159/000328901, ISSN: 1421-9670.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21677428.
  • Hadley J, Yabroff KR, Barrett MJ, Penson DF, Saigal CS, Potosky AL. Comparative effectiveness of prostate cancer treatments: evaluating statistical adjustments for confounding in observational data. J. Natl. Cancer Inst [print-electronic]. 2010 Dec 12/1/2010; 102(23): 1780-93. PMID: 20944078, PMCID: PMC2994860, PII: djq393, DOI: 10.1093/jnci/djq393, ISSN: 1460-2105.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20944078.
  • Stimson CJ, Dmochowski R, Penson DF. Health care reform 2010: a fresh view on tort reform. J. Urol [print-electronic]. 2010 Nov; 184(5): 1840-6. PMID: 20846694, PII: S0022-5347(10)04065-6, DOI: 10.1016/j.juro.2010.06.143, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20846694.
  • Barocas DA, Penson DF. Racial variation in the pattern and quality of care for prostate cancer in the USA: mind the gap. BJU Int [print-electronic]. 2010 Aug; 106(3): 322-8. PMID: 20553251, PMCID: PMC2910169, PII: BJU9467, DOI: 10.1111/j.1464-410X.2010.09467.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20553251.
  • Zeliadt SB, Ramsey SD, Van Den Eeden SK, Hamilton AS, Oakley-Girvan I, Penson DF, Fairweather ME, Arora NK, Potosky AL. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Am. J. Clin. Oncol. 2010 Aug; 33(4): 381-6. PMID: 20010079, DOI: 10.1097/COC.0b013e3181b215d5, ISSN: 1537-453X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20010079.
  • Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, Redfern CH, Ferrari AC, Dreicer R, Sims RB, Xu Y, Frohlich MW, Schellhammer PF, . Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 2010 Jul 7/29/2010; 363(5): 411-22. PMID: 20818862, DOI: 10.1056/NEJMoa1001294, ISSN: 1533-4406.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20818862.
  • Ramsey SD, Zeliadt SB, Arora NK, Blough DK, Penson DF, Oakley-Girvan I, Hamilton AS, Van Den Eeden SK, Fedorenko CR, Potosky AL. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J. Urol [print-electronic]. 2010 Jul; 184(1): 120-5. PMID: 20478590, PII: S0022-5347(10)02996-4, DOI: 10.1016/j.juro.2010.03.023, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20478590.
  • Huang GJ, Sadetsky N, Penson DF. Health related quality of life for men treated for localized prostate cancer with long-term followup. J. Urol. 2010 Jun; 183(6): 2206-12. PMID: 20399462, PMCID: PMC4575915, PII: S0022-5347(10)00254-5, DOI: 10.1016/j.juro.2010.02.013, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20399462.
  • Zeliadt SB, Moinpour CM, Blough DK, Penson DF, Hall IJ, Smith JL, Ekwueme DU, Thompson IM, Keane TE, Ramsey SD. Preliminary treatment considerations among men with newly diagnosed prostate cancer. Am J Manag Care. 2010 May; 16(5): e121-30. PMID: 20455638, PII: 12633, ISSN: 1936-2692.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20455638.
  • Makarov DV, Loeb S, Landman AB, Nielsen ME, Gross CP, Leslie DL, Penson DF, Desai RA. Regional variation in total cost per radical prostatectomy in the healthcare cost and utilization project nationwide inpatient sample database. J. Urol [print-electronic]. 2010 Apr; 183(4): 1504-9. PMID: 20172559, PII: S0022-5347(09)03178-4, DOI: 10.1016/j.juro.2009.12.014, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20172559.
  • Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J. Clin. Oncol [print-electronic]. 2010 Feb 2/20/2010; 28(6): 1069-74. PMID: 20100957, PMCID: PMC2834431, PII: JCO.2009.26.2469, DOI: 10.1200/JCO.2009.26.2469, ISSN: 1527-7755.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20100957.
  • Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. J. Urol [print-electronic]. 2009 Nov; 182(5): 2182-7. PMID: 19758623, PII: S0022-5347(09)01741-8, DOI: 10.1016/j.juro.2009.07.017, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19758623.
  • Penson DF. Active surveillance: not your father's watchful waiting. Oncology (Williston Park, N.Y.). 2009 Oct; 23(11): 980-2. PMID: 19947350, PII: 166280, ISSN: 0890-9091.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19947350.
  • Makarov DV, Penson DF. Prostate cancer: quality of life after radiation and androgen deprivation. Nature reviews. Urology. 2009 Sep; 6(9) Sect. 477,8.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19727147.
  • Ramsey SD, Zeliadt SB, Arora NK, Potosky AL, Blough DK, Hamilton AS, Van Den Eeden SK, Oakley-Girvan I, Penson DF. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology [print-electronic]. 2009 Sep; 74(3): 509-15. PMID: 19589564, PMCID: PMC2748115, PII: S0090-4295(09)00441-5, DOI: 10.1016/j.urology.2009.01.090, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19589564.
  • Penson DF, Wessells H, Cleary P, Rutledge BN, . Sexual dysfunction and symptom impact in men with long-standing type 1 diabetes in the DCCT/EDIC cohort. J Sex Med [print-electronic]. 2009 Jul; 6(7): 1969-78. PMID: 19453899, PMCID: PMC2861494, PII: JSM1292, DOI: 10.1111/j.1743-6109.2009.01292.x, ISSN: 1743-6109.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19453899.
  • Nichol MB, Knight TK, Wu J, Barron R, Penson DF. Evaluating use patterns of and adherence to medications for benign prostatic hyperplasia. J. Urol [print-electronic]. 2009 May; 181(5): 2214-21; discussion 2221. PMID: 19296986, PII: S0022-5347(09)00055-X, DOI: 10.1016/j.juro.2009.01.033, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19296986.
  • Stein JP, Penson DF, Lee C, Cai J, Miranda G, Skinner DG. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. J. Urol [print-electronic]. 2009 May; 181(5): 2052-8; discussion 2058. PMID: 19286213, PII: S0022-5347(09)00042-1, DOI: 10.1016/j.juro.2009.01.020, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19286213.
  • Penson DF, Rossignol M, Sartor AO, Scardino PT, Abenhaim LL. Prostate cancer: epidemiology and health-related quality of life. Urology. 2008 Dec; 72(6 Suppl): S3-11. PMID: 19095126, PII: S0090-4295(08)01734-2, DOI: 10.1016/j.urology.2008.10.006, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19095126.
  • Huang GJ, Hamilton AS, Lo M, Stein JP, Penson DF. Predictors of intravesical therapy for nonmuscle invasive bladder cancer: results from the surveillance, epidemiology and end results program 2003 patterns of care project. J. Urol [print-electronic]. 2008 Aug; 180(2): 520-4; discussion 524. PMID: 18550088, PMCID: PMC3327445, PII: S0022-5347(08)00945-2, DOI: 10.1016/j.juro.2008.04.016, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18550088.
  • Stein JP, Penson DF. Invasive T1 bladder cancer: indications and rationale for radical cystectomy. BJU Int [print-electronic]. 2008 Aug; 102(3): 270-5. PMID: 18494831, PII: BJU7743, DOI: 10.1111/j.1464-410X.2008.07743.x, ISSN: 1464-410X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18494831.
  • Etzioni R, Gulati R, Falcon S, Penson DF. Impact of PSA screening on the incidence of advanced stage prostate cancer in the United States: a surveillance modeling approach. Med Decis Making [print-electronic]. 2008 May; 28(3): 323-31. PMID: 18319508, PII: 0272989X07312719, DOI: 10.1177/0272989X07312719, ISSN: 0272-989X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18319508.
  • Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J. Urol. 2008 May; 179(5 Suppl): S40-4. PMID: 18405749, PII: S0022-5347(08)00737-4, DOI: 10.1016/j.juro.2008.03.136, ISSN: 1527-3792.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18405749.
  • Stein JP, Penson DF. The invasive T1 bladder tumor: contemporary issues and rationale for radical cystectomy. Curr Urol Rep. 2008 May; 9(3): 179-81. PMID: 18765110, ISSN: 1534-6285.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18765110.
  • Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, Wegelin J, DiTommaso D, Karnofski K, Gulati R, Penson DF, Feuer E. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control [print-electronic]. 2008 Mar; 19(2): 175-81. PMID: 18027095, PMCID: PMC3064270, DOI: 10.1007/s10552-007-9083-8, ISSN: 0957-5243.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18027095.
  • Huang GJ, Penson DF. Internet health resources and the cancer patient. Cancer Invest. 2008 Mar; 26(2): 202-7. PMID: 18259953, PII: 785208482, DOI: 10.1080/07357900701566197, ISSN: 1532-4192.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18259953.
  • Lloyd A, Penson D, Dewilde S, Kleinman L. Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer. Prostate Cancer Prostatic Dis [print-electronic]. 2008; 11(2): 153-9. PMID: 17637761, PII: 4500992, DOI: 10.1038/sj.pcan.4500992, ISSN: 1476-5608.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17637761.
  • Stein JP, Penson DF, Wu SD, Skinner DG. Pathological guidelines for orthotopic urinary diversion in women with bladder cancer: a review of the literature. J. Urol [print-electronic]. 2007 Sep; 178(3 Pt 1): 756-60. PMID: 17631333, PII: S0022-5347(07)01220-7, DOI: 10.1016/j.juro.2007.05.013, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17631333.
  • Gonzalez CM, Penson D, Kosiak B, Dupree J, Clemens JQ. Pay for performance: rationale and potential implications for urology. J. Urol [print-electronic]. 2007 Aug; 178(2): 402-8. PMID: 17561159, PII: S0022-5347(07)00743-4, DOI: 10.1016/j.juro.2007.03.095, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17561159.
  • Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF. On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J. Urol. 2007 Jun; 177(6): 1992-9. PMID: 17509278, PII: S0022-5347(07)00276-5, DOI: 10.1016/j.juro.2007.01.138, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17509278.
  • Graff JN, Mori M, Li H, Garzotto M, Penson D, Potosky AL, Beer TM. Predictors of overall and cancer-free survival of patients with localized prostate cancer treated with primary androgen suppression therapy: results from the prostate cancer outcomes study. J. Urol. 2007 Apr; 177(4): 1307-12. PMID: 17382720, PII: S0022-5347(06)03125-9, DOI: 10.1016/j.juro.2006.11.054, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17382720.
  • Singer EA, Penson DF, Palapattu GS. PSA screening and elderly men [letter]. JAMA. 2007 Mar 3/7/2007; 297(9): 949; author reply 949-50. PMID: 17341705, PII: 297/9/949, DOI: 10.1001/jama.297.9.949-a, ISSN: 1538-3598.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17341705.
  • Albertsen PC, Hanley JA, Penson DF, Barrows G, Fine J. 13-year outcomes following treatment for clinically localized prostate cancer in a population based cohort. J. Urol. 2007 Mar; 177(3): 932-6. PMID: 17296379, PII: S0022-5347(06)02749-2, DOI: 10.1016/j.juro.2006.10.051, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17296379.
  • Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, Groshen S, Lieskovsky G, Skinner DG. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J. Urol. 2007 Mar; 177(3): 876-81; discussion 881. PMID: 17296365, PII: S0022-5347(06)02757-1, DOI: 10.1016/j.juro.2006.10.043, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17296365.
  • Zeliadt SB, Etzioni R, Ramsey SD, Penson DF, Potosky AL. Trends in treatment costs for localized prostate cancer: the healthy screenee effect. Med Care. 2007 Feb; 45(2): 154-9. PMID: 17224778, PII: 00005650-200702000-00008, DOI: 10.1097/01.mlr.0000241044.09778.3f, ISSN: 0025-7079.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17224778.
  • Zeliadt SB, Penson DF. Pharmacoeconomics of available treatment options for metastatic prostate cancer. Pharmacoeconomics. 2007; 25(4): 309-27. PMID: 17402804, PII: 2544, ISSN: 1170-7690.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17402804.
  • Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEED. J Sex Med. 2006 Nov; 3(6): 1059-67. PMID: 17100939, PII: JSM331, DOI: 10.1111/j.1743-6109.2006.00331.x, ISSN: 1743-6095.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17100939.
  • Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Longitudinal differences in psychological outcomes for men with erectile dysfunction: results from ExCEED. J Sex Med. 2006 Nov; 3(6): 1068-76. PMID: 17100940, PII: JSM332, DOI: 10.1111/j.1743-6109.2006.00332.x, ISSN: 1743-6095.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17100940.
  • Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G, Skinner DG. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J. Urol. 2006 Nov; 176(5): 2025-31; discussion 2031. PMID: 17070244, PII: S0022-5347(06)01767-8, DOI: 10.1016/j.juro.2006.07.075, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/17070244.
  • Zeliadt SB, Potosky AL, Penson DF, Etzioni R. Survival benefit associated with adjuvant androgen deprivation therapy combined with radiotherapy for high- and low-risk patients with nonmetastatic prostate cancer. Int. J. Radiat. Oncol. Biol. Phys [print-electronic]. 2006 Oct 10/1/2006; 66(2): 395-402. PMID: 16904843, PII: S0360-3016(06)00943-6, DOI: 10.1016/j.ijrobp.2006.04.048, ISSN: 0360-3016.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16904843.
  • Penson D, Moul J, Gandhi S, Newling D. Use of prostate-specific antigen in the follow-up of patients with localized prostate cancer: results of a nationwide survey of urologists. Urology [print-electronic]. 2006 Jul; 68(1): 80-4. PMID: 16777198, PII: S0090-4295(06)00097-5, DOI: 10.1016/j.urology.2006.01.028, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16777198.
  • Yang CC, Porter MP, Penson DF. Comparison of the International Index of Erectile Function erectile domain scores and nocturnal penile tumescence and rigidity measurements: does one predict the other?. BJU Int. 2006 Jul; 98(1): 105-9; discussion 109. PMID: 16831153, PII: BJU6246, DOI: 10.1111/j.1464-410X.2006.06246.x, ISSN: 1464-4096.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16831153.
  • Black PC, Penson DF. Prostate cancer on the Internet--information or misinformation?. J. Urol. 2006 May; 175(5): 1836-42; discussion 1842. PMID: 16600774, PII: S0022-5347(05)00996-1, DOI: 10.1016/S0022-5347(05)00996-1, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16600774.
  • Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M, Penson D. Is combined androgen blockade with bicalutamide cost-effective compared with combined androgen blockade with flutamide?. Urology. 2005 Oct; 66(4): 835-9. PMID: 16230148, PII: S0090-4295(05)00531-5, DOI: 10.1016/j.urology.2005.04.028, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16230148.
  • Albertsen PC, Hanley JA, Barrows GH, Penson DF, Kowalczyk PD, Sanders MM, Fine J. Prostate cancer and the Will Rogers phenomenon. J. Natl. Cancer Inst. 2005 Sep 9/7/2005; 97(17): 1248-53. PMID: 16145045, PII: 97/17/1248, DOI: 10.1093/jnci/dji248, ISSN: 1460-2105.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16145045.
  • Penson DF, Ramsey S, Veenstra D, Clarke L, Gandhi S, Hirsch M. The cost-effectiveness of combined androgen blockade with bicalutamide and luteinizing hormone releasing hormone agonist in men with metastatic prostate cancer. J. Urol. 2005 Aug; 174(2): 547-52; discussion 552. PMID: 16006889, PII: S0022-5347(01)68304-6, DOI: 10.1097/01.ju.0000165569.48372.4c, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16006889.
  • Zeliadt SB, Etzioni RD, Penson DF, Thompson IM, Ramsey SD. Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer. Am. J. Med. 2005 Aug; 118(8): 850-7. PMID: 16084177, PII: S0002-9343(05)00171-3, DOI: 10.1016/j.amjmed.2005.03.001, ISSN: 0002-9343.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/16084177.
  • Penson DF, McLerran D, Feng Z, Li L, Albertsen PC, Gilliland FD, Hamilton A, Hoffman RM, Stephenson RA, Potosky AL, Stanford JL. 5-year urinary and sexual outcomes after radical prostatectomy: results from the prostate cancer outcomes study. J. Urol. 2005 May; 173(5): 1701-5. PMID: 15821561, PII: S0022-5347(05)60698-2, DOI: 10.1097/01.ju.0000154637.38262.3a, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15821561.
  • Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J. Urol. 2005 Apr; 173(4): 1318-22. PMID: 15758789, PII: S0022-5347(05)61089-0, DOI: 10.1097/01.ju.0000149080.82697.65, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15758789.
  • Zeliadt SB, Potosky AL, Etzioni R, Ramsey SD, Penson DF. Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999. Urology. 2004 Dec; 64(6): 1171-6. PMID: 15596192, PII: S0090-4295(04)00969-0, DOI: 10.1016/j.urology.2004.07.037, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15596192.
  • Rosenfeld B, Roth AJ, Gandhi S, Penson D. Differences in health-related quality of life of prostate cancer patients based on stage of cancer. Psychooncology. 2004 Nov; 13(11): 800-7. PMID: 15386638, DOI: 10.1002/pon.797, ISSN: 1057-9249.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15386638.
  • Johnson TK, Gilliland FD, Hoffman RM, Deapen D, Penson DF, Stanford JL, Albertsen PC, Hamilton AS. Racial/Ethnic differences in functional outcomes in the 5 years after diagnosis of localized prostate cancer. J. Clin. Oncol. 2004 Oct 10/15/2004; 22(20): 4193-201. PMID: 15483030, PII: 22/20/4193, DOI: 10.1200/JCO.2004.09.127, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15483030.
  • Potosky AL, Davis WW, Hoffman RM, Stanford JL, Stephenson RA, Penson DF, Harlan LC. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J. Natl. Cancer Inst. 2004 Sep 9/15/2004; 96(18): 1358-67. PMID: 15367568, PII: 96/18/1358, DOI: 10.1093/jnci/djh259, ISSN: 1460-2105.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15367568.
  • Neuhouser ML, Kristal AR, Penson DF. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature. Urology. 2004 Aug; 64(2): 201-11. PMID: 15302461, PII: S0090429504005175, DOI: 10.1016/j.urology.2004.04.025, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15302461.
  • Inoue LY, Etzioni R, Slate EH, Morrell C, Penson DF. Combining longitudinal studies of PSA. Biostatistics. 2004 Jul; 5(3): 483-500. PMID: 15208207, PII: 5/3/483, DOI: 10.1093/biostatistics/5.3.483, ISSN: 1465-4644.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15208207.
  • Albertsen PC, Hanley JA, Penson DF, Fine J. Validation of increasing prostate specific antigen as a predictor of prostate cancer death after treatment of localized prostate cancer with surgery or radiation. J. Urol. 2004 Jun; 171(6 Pt 1): 2221-5. PMID: 15126789, PII: 00005392-200406000-00025, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15126789.
  • Penson DF, Moul JW, Evans CP, Doyle JJ, Gandhi S, Lamerato L. The economic burden of metastatic and prostate specific antigen progression in patients with prostate cancer: findings from a retrospective analysis of health plan data. J. Urol. 2004 Jun; 171(6 Pt 1): 2250-4. PMID: 15126796, PII: 00005392-200406000-00032, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/15126796.
  • Zeliadt SB, Penson DF, Albertsen PC, Concato J, Etzioni RD. Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis. Cancer. 2003 Aug 8/1/2003; 98(3): 496-503. PMID: 12879465, DOI: 10.1002/cncr.11492, ISSN: 0008-543X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12879465.
  • Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol. Biomarkers Prev. 2003 Jul; 12(7): 604-9. PMID: 12869398, ISSN: 1055-9965.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12869398.
  • Latini DM, Penson DF, Lubeck DP, Wallace KL, Henning JM, Lue TF. Longitudinal differences in disease specific quality of life in men with erectile dysfunction: results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction study. J. Urol. 2003 Apr; 169(4): 1437-42. PMID: 12629379, PII: S0022-5347(05)63777-9, DOI: 10.1097/01.ju.0000049203.33463.9e, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12629379.
  • Penson DF, Latini DM, Lubeck DP, Wallace K, Henning JM, Lue T. Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base. J. Urol. 2003 Apr; 169(4): 1458-61. PMID: 12629383, DOI: 10.1097/01.ju.0000054462.88306.43, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12629383.
  • Penson DF, Latini DM, Lubeck DP, Wallace KL, Henning JM, Lue TF, . Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database. Diabetes Care. 2003 Apr; 26(4): 1093-9. PMID: 12663579, ISSN: 0149-5992.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12663579.
  • Penson DF, Feng Z, Kuniyuki A, McClerran D, Albertsen PC, Deapen D, Gilliland F, Hoffman R, Stephenson RA, Potosky AL, Stanford JL. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J. Clin. Oncol. 2003 Mar 3/15/2003; 21(6): 1147-54. PMID: 12637483, ISSN: 0732-183X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12637483.
  • Penson DF, Paltiel AD, Krumholz HM, Palter S. The cost-effectiveness of treatment for varicocele related infertility. J. Urol. 2002 Dec; 168(6): 2490-4. PMID: 12441947, PII: S0022-5347(05)64175-4, DOI: 10.1097/01.ju.0000037487.02503.da, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12441947.
  • Latini DM, Penson DF, Colwell HH, Lubeck DP, Mehta SS, Henning JM, Lue TF. Psychological impact of erectile dysfunction: validation of a new health related quality of life measure for patients with erectile dysfunction. J. Urol. 2002 Nov; 168(5): 2086-91. PMID: 12394715, PII: S0022-5347(05)64302-9, DOI: 10.1097/01.ju.0000034365.57110.b7, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12394715.
  • Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J. Natl. Cancer Inst. 2002 Jul 7/3/2002; 94(13): 981-90. PMID: 12096083, ISSN: 0027-8874.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12096083.
  • Penson DF, Grossfeld GD, Li YP, Henning JM, Lubeck DP, Carroll PR. How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavor. J. Urol. 2002 Apr; 167(4): 1653-7; discussion 1657. PMID: 11912382, PII: S0022-5347(05)65172-5, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11912382.
  • Penson DF, Albertsen PC, Nelson PS, Barry M, Stanford JL. Determining cause of death in prostate cancer: are death certificates valid?. J. Natl. Cancer Inst. 2001 Dec 12/5/2001; 93(23): 1822-3. PMID: 11734600, ISSN: 0027-8874.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11734600.
  • Penson DF, Stoddard ML, Pasta DJ, Lubeck DP, Flanders SC, Litwin MS. The association between socioeconomic status, health insurance coverage, and quality of life in men with prostate cancer. J Clin Epidemiol. 2001 Apr; 54(4): 350-8. PMID: 11297885, PII: S0895-4356(00)00312-7, ISSN: 0895-4356.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11297885.
  • Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll PR, Litwin MS. Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology. 2001 Mar; 57(3): 499-503. PMID: 11248628, PII: S0090-4295(00)01033-5, ISSN: 1527-9995.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11248628.
  • Corman JM, Penson DF, Hur K, Khuri SF, Daley J, Henderson W, Krieger JN. Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program. BJU Int. 2000 Nov; 86(7): 782-9. PMID: 11069401, PII: bju919, ISSN: 1464-4096.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/11069401.
  • Taneja SS, Penson DF, Epelbaum A, Handler T, Lepor H. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen. J. Urol. 1999 Oct; 162(4): 1352-7; discussion 1357. PMID: 10492195, PII: S0022-5347(05)68284-5, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/10492195.
  • Penson DF, Litwin MS, Lubeck DP, Flanders S, Pasta DJ, Carroll PR. Transitions in health-related quality of life during the first nine months after diagnosis with prostate cancer. Prostate Cancer Prostatic Dis. 1998 Mar; 1(3): 134-43. PMID: 12496906, PII: 4500228, DOI: 10.1038/sj.pcan.4500228, ISSN: 1476-5608.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/12496906.
  • Penson DF, Lugg JA, Coyne C, Sadeghi F, Freedman AL, Gonzalez-Cadavid NF, Rajfer J. Effect of cryptorchidism on testicular histology in a naturally cryptorchid animal model. J. Urol. 1997 Nov; 158(5): 1978-82. PMID: 9334653, PII: S0022-5347(01)64197-1, ISSN: 0022-5347.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9334653.
  • Penson DF, Ng C, Rajfer J, Gonzalez-Cadavid NF. Adrenal control of erectile function and nitric oxide synthase in the rat penis. Endocrinology. 1997 Sep; 138(9): 3925-32. PMID: 9275083, DOI: 10.1210/endo.138.9.5402, ISSN: 0013-7227.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9275083.
  • Lugg JA, Penson DF, Sadeghi F, Petrie B, Freedman AL, Gonzalez-Cadavid NF, Hikim AS, Rajfer J. Prevention of seminiferous tubular atrophy in a naturally cryptorchid rat model by early surgical intervention. J. Androl. 1996 Nov; 17(6): 726-32. PMID: 9016404, ISSN: 0196-3635.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/9016404.